Guerra Fiona M, Rosella Laura C, Dunn Sheila, Wilson Sarah E, Chen Cynthia, Deeks Shelley L
Public Health Ontario, Toronto, Ontario, Canada.
Public Health Ontario, Toronto, Ontario, Canada Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
BMJ Open. 2016 Mar 10;6(3):e009914. doi: 10.1136/bmjopen-2015-009914.
Trends in occurrence of anogenital warts (AGWs) can provide early evidence of human papillomavirus (HPV) vaccination programme impact on preventing HPV infection and HPV-induced lesions. The objective of this study was to provide a baseline of AGW epidemiology in Ontario prior to the introduction of the publicly-funded school-based HPV vaccination programme in September 2007.
As a retrospective longitudinal population-based study, we used health administrative data as a proxy to estimate incident AGWs and total health service utilisation (HSU) for AGWs for all Ontario residents 15 years and older with valid health cards between 1 April 2003 and 31 March 2007.
The outcome of interest was AGW healthcare utilisation identified using the International Classification of Diseases, 10th revision (ICD-10) diagnostic code for AGWs, as well as an algorithm for identifying AGW physician office visits in a database with a unique system of diagnostic and procedural codes. An AGW case was considered incident if preceded by 12 months without HSU for AGWs. Time trends by age group and sex were analysed.
Between fiscal years 2003 and 2006, we identified 123,247 health service visits for AGWs by 51,436 Ontario residents 15 years and older. Incident AGWs peaked in females and males in the 21-23 year age group, at 3.74 per 1000 and 2.81 per 1000, respectively. HSU for AGWs peaked in females and males within the 21-23 year age group, at 9.34 per 1000 and 7.22 per 1000, respectively.
To the best of our knowledge, this is the first population-based study of AGW incidence and HSU in Ontario. The sex and age distribution of individuals with incident and prevalent AGWs in Ontario was similar to that of other provinces before HPV vaccine programme implementation in Canada.
肛门生殖器疣(AGW)的发病趋势可为人类乳头瘤病毒(HPV)疫苗接种计划对预防HPV感染及HPV所致病变的影响提供早期证据。本研究的目的是在2007年9月引入由公共资金支持的基于学校的HPV疫苗接种计划之前,提供安大略省AGW流行病学的基线数据。
作为一项基于人群的回顾性纵向研究,我们使用卫生行政数据作为替代指标,来估算2003年4月1日至2007年3月31日期间,安大略省所有15岁及以上持有有效健康卡居民的AGW发病情况及AGW的总医疗服务利用率(HSU)。
感兴趣的观察指标是使用国际疾病分类第10版(ICD-10)中AGW的诊断编码,以及在一个具有独特诊断和程序编码系统的数据库中识别AGW医生门诊就诊的算法,来确定AGW的医疗服务利用情况。如果在12个月内没有AGW的医疗服务利用情况,则将AGW病例视为新发病例。分析了按年龄组和性别的时间趋势。
在2003财年至2006财年期间,我们确定安大略省15岁及以上的51436名居民进行了123247次AGW医疗服务就诊。新发AGW在21-23岁年龄组的女性和男性中达到峰值,分别为每1000人3.74例和每1000人2.81例。AGW的HSU在21-23岁年龄组的女性和男性中达到峰值,分别为每1000人9.34例和每1000人7.22例。
据我们所知,这是安大略省第一项基于人群的AGW发病率和HSU研究。在加拿大实施HPV疫苗接种计划之前,安大略省新发和现患AGW个体的性别和年龄分布与其他省份相似。